{
    "symbol": "CYRX",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-06 10:38:04",
    "content": " Yes, I mean, just obviously if you look at the guidance, we're clearly looking at the supply chain issues, the foreign exchange, and we still feel very strong about the revenue that we can achieve for the full year. In closing first quarter 2022 was, you had another quarter demonstrating our leadership position in temperature control, supply chain solutions for the life sciences industry, supporting our markets of biopharma, animal health and reproductive medicine, and especially the life-saving cell and gene therapies across the clinical and commercial spectrum."
}